ELLYID
LIVE

Serial Number

79393230

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Feb 5, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ELLYID Trademark

Serial Number: 79393230 • Registration: 7637034

ELLYID is a trademark filed by NOVARTIS AG on February 5, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,165 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

February 5, 2024

Registration Date

January 7, 2025

Published for Opposition

September 17, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 27, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 10, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 10, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 6, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 7, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 7, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 17, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 17, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 28, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 9, 2024 CNSA
ASSIGNED TO EXAMINER
Aug 9, 2024 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 13, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 13, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 13, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 13, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 13, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 13, 2024 COAR
APPLICATION FILING RECEIPT MAILED
Apr 23, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 18, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 16, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 11, 2024 REPR